Compare IAM & NFGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IAM | NFGC |
|---|---|---|
| Founded | 2019 | 2016 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 683.0M | 618.8M |
| IPO Year | 2026 | 2021 |
| Metric | IAM | NFGC |
|---|---|---|
| Price | $15.48 | $1.63 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $24.67 | N/A |
| AVG Volume (30 Days) | 648.2K | ★ 1.3M |
| Earning Date | 11-23-2026 | 08-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $225.80 | $1,227.71 |
| Revenue Next Year | $150.81 | $134.53 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.60 | $1.34 |
| 52 Week High | $24.49 | $3.59 |
| Indicator | IAM | NFGC |
|---|---|---|
| Relative Strength Index (RSI) | 33.63 | 49.93 |
| Support Level | $12.52 | $1.62 |
| Resistance Level | $16.50 | $1.76 |
| Average True Range (ATR) | 1.84 | 0.11 |
| MACD | 0.31 | 0.01 |
| Stochastic Oscillator | 79.71 | 51.39 |
Iambic Therapeutics Inc is a technology and clinical-stage life sciences company developing novel medicines using its proprietary molecular superintelligence platform.
New Found Gold Corp is a mineral exploration company engaged in the acquisition, exploration and evaluation of resource properties with a focus on gold properties located in the Provinces of Newfoundland and Labrador and Ontario, Canada. The Companies exploration is focused on discovering and delineating gold resources. The Company has one material property: the Queensway Project located in Newfoundland, Canada (the Queensway Project).